The purpose of our study was to investigate whether sonography an adjunctive imaging for determining benign or malignancy lesions in breast microcalcification after screening mammography. According to BI-RADS assessment categories systems, category 4 or 5 needed further tissue proof. This retrospective study enrolled patients in St. Paul hospital who underwent tissue proof between May 1, 2011 to March 31, 2017. All patients with microcalcification in screening mammography were divided into two subgroups: the group of BI-RADS 0 initially then turn into BI-RADS 4 or 5 after magnified mammography (group A) and the other group of BI-RADS 4 or 5 (group B). We excluded patients with incomplete data including no tissue proof or no sonography report in our hospital. We evaluate the correlation between the pathologic results and the sonographic findings. A total of 133 patients were reviewed, 105 (78.9%) patients were group A. Among 105 specimens in the group A, 23 (21.9%) were proved malignancy. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of sonography were 52%, 84.1%, 48%, 86.3%, and 77.1%, respectively. Sixteen (57.1%) out of 28 patients in the group B were malignant. The findings of sonogrpahy showed high sensitivity, specificity, PPV, NPV, and accuracy for malignancy (87.5%, 75%, 82.4%, 81.8%, and 82.1%, respectively). Sonography could provide good specificity in undetermined microcalfication. A biopsy may be avoided if microcalcifications in mammography appear absolutely benign on sonography and those patients can be followed-up with interval serial exam.
Read full abstract